NASDAQ:ELYM
Eliem Therapeutics, Inc.
- Stock
Last Close
8.18
17/05 20:00
Market Cap
79.27M
Beta: -
Volume Today
318.37K
Avg: 17.85K
PE Ratio
−1.98
PFCF: −2.60
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
asset turnover | ||||||
cash per share | 3.10 - | 1.76 43.41% | 11.13 533.64% | 4.70 57.81% | 3.96 15.73% | |
company equity multiplier | 1.04 - | 1.14 10.02% | 1.04 9.27% | 1.05 1.22% | 1.03 2.11% | |
days of inventory outstanding | ||||||
days of payables outstanding | ||||||
days of sales outstanding | ||||||
dividend yield | ||||||
ebit per revenue | ||||||
ebt per ebit | 0.88 - | 0.99 12.33% | 1.33 34.76% | 1.00 24.69% | 0.87 13.01% | |
effective tax rate | 0.42 - | 0.44 5.49% | -0.00 - | |||
enterprise value multiple | -45.30 - | -57.55 27.03% | -2.29 96.02% | -1.22 46.54% | 0.49 140.34% | |
fixed asset turnover | ||||||
free cash flow per share | -0.73 - | -1.21 65.04% | -2.94 143.37% | -1.42 51.73% | -0.76 46.26% | |
gross profit margin | ||||||
interest coverage | -28.33 - | |||||
inventory turnover | ||||||
long term debt to capitalization | 0.00 - | 0.00 90.02% | ||||
net income per ebt | 0.58 - | 0.56 3.98% | 1 79.57% | 1.00 0.24% | 1 0.24% | |
net profit margin | ||||||
operating cash flow per share | -0.73 - | -1.21 65.04% | -2.94 143.37% | -1.42 51.73% | -0.76 46.26% | |
operating profit margin | ||||||
payables turnover | ||||||
pretax profit margin | ||||||
price fair value | 5.27 - | 8.60 63.01% | 0.77 91.08% | 0.75 2.19% | 0.68 9.73% | |
receivables turnover | ||||||
return on assets | -0.18 - | -0.47 163.31% | -0.27 41.35% | -0.34 22.59% | -0.32 5.38% | |
return on capital employed | -0.36 - | -0.97 168.57% | -0.21 78.01% | -0.35 64.14% | -0.37 6.86% | |
return on equity | -0.18 - | -0.53 189.70% | -0.28 46.79% | -0.35 24.08% | -0.33 7.37% | |
total debt to capitalization | 0.00 - | 0.00 12.98% |
All numbers in USD (except ratios and percentages)